Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca a Cancer J Clinicians. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Katsura C, Ogunmwonyi I, Kankam HK, et al. Breast cancer: presentation, investigation and management. Br J Hosp Med. 2022;83(2):1–7. doi:10.12968/hmed.2021.0459
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. doi:10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• Chaudhary LN, Wilkinson KH. Triple-Negative Breast Cancer: who Should Receive Neoadjuvant Chemotherapy? Surgical Oncol Clin North Am. 2018;27(1):141–153. doi:10.1016/j.soc.2017.08.004
   PubMed Web of Science ®Google Scholar
• Di Maio M, Gallo C, Leighl NB. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J clin oncol. 2015. doi:10.1200/JCO.2014.57.9334
   Web of Science ®Google Scholar
• Qing J, Fangshi Z, Xuan L, et al. Recent Advance in Applications of Proteomics Technologies on Traditional Chinese Medicine Research. Evidence-Based Complementray Altern Med. 2015:983139. doi:10.1155/2015/983139
   PubMed Web of Science ®Google Scholar
• Chen J, Qin Y, Sun C, et al. Clinical study on postoperative triple-negative breast cancer with Chinese medicine: study protocol for an observational cohort trial. Medicine. 2018;97(25):e11061. doi:10.1097/MD.0000000000011061
   PubMed Web of Science ®Google Scholar
• Li F, Shi Y, Zhang Y, et al. Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway. ChinMed. 2022;17(1):44. doi:10.1186/s13020-022-00597-5
   Google Scholar
• Chen JL, Chang CJ, Wang JY, et al. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen. Integr Cancer Ther. 2014;13(3):226. doi:10.1177/1534735414520970
   PubMed Web of Science ®Google Scholar
• Li X, Wei S, Niu S, et al. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis. Comput. Biol. Med. 2022;144:105389. doi:10.1016/j.compbiomed.2022.105389
   PubMed Web of Science ®Google Scholar
• Zhou W, Zhang H, Wang X, et al. Network pharmacology to unveil the mechanism of Moluodan in the treatment of chronic atrophic gastritis. Phytomedicine. 2021;95:153837. doi:10.1016/j.phymed.2021.153837
   PubMed Web of Science ®Google Scholar
• Wu D, Wang X. Application of clinical bioinformatics in lung cancer-specific biomarkers. Cancer Metastasis Rev. 2015;34(2):209–216. doi:10.1007/s10555-015-9564-2
   PubMed Web of Science ®Google Scholar
• Xiang Y, Guo Z, Zhu P, et al. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 2019;8(5):1958–1975. doi:10.1002/cam4.2108
   PubMed Web of Science ®Google Scholar
• Xu Z, Jin Y, Gao Z, et al. Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib. Autophagy. 2021:1–22. doi:10.1080/15548627.2021.1965712
   PubMedGoogle Scholar
• Zhang Z, Liu J, Liu Y, et al. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation. J Ethnopharmacol. 2021;269:113696. doi:10.1016/j.jep.2020.113696
   PubMed Web of Science ®Google Scholar
• Umar SM, Patra S, Kashyap A, et al. Quercetin Impairs HuR-Driven Progression and Migration of Triple Negative Breast Cancer (TNBC) Cells. Nutr Cancer. 2022;74(4):1497–1510. doi:10.1080/01635581.2021.1952628
   PubMed Web of Science ®Google Scholar
• Gol M, Kheirouri S. The Effects of Quercetin on the Apoptosis of Human Breast Cancer Cell Lines MCF-7 and MDA-MB-231: a Systematic Review. Nutr Cancer. 2022;74(2):405–422. doi:10.1080/01635581.2021.1897631
   PubMed Web of Science ®Google Scholar
• Ozkan E, Bakar-Ates F. Potentiation of the effect of Lonidamine by Quercetin in MCF-7 human breast cancer cells through downregulation of MMP-2/9 mRNA Expression. Acad Bras Cienc. 2020;92(4):e20200548.43. doi:10.1590/0001-3765202020200548
   PubMed Web of Science ®Google Scholar
• Tsai KJ, Tsai HY, Tsai CC, et al. Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway. Molecules. 2021;26(21):6452. doi:10.3390/molecu-les26216452
   PubMed Web of Science ®Google Scholar
• Khan Z, Nath N, Rauf A, et al. Multifunctional roles and pharmacological potential of β-sitosterol: emerging evidence toward clinical applications. Chem Biol Interact. 2022;365:110117. doi:10.1016/j.cbi.2022.110117
   PubMed Web of Science ®Google Scholar
• Wang KN, Hu Y, Han LL, et al. Salvia chinensis Benth Inhibits Triple-Negative Breast Cancer Progression by Inducing the DNA Damage Pathway. Front Oncol. 2022;12:882784. doi:10.3389/fonc.2022.882784
   PubMed Web of Science ®Google Scholar
• Wu SY, Xiao Y, Wei JL, et al. MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer. J Immunother Cancer. 2021;9(7):e002528. doi:10.1136/jitc-2021-002528
   PubMed Web of Science ®Google Scholar
• Soucek L, Evan GI. The ups and downs of Myc biology. Curr Opin Genet Dev. 2010;20(1):91–95. doi:10.1016/j.gde.2009.11.001
   PubMed Web of Science ®Google Scholar
• Li J, Gao X, Zhang Z, et al. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes. Mol Cancer. 2021;20(1):138. doi:10.1186/s12943-021-01444-1
   PubMed Web of Science ®Google Scholar
• Beroske L, Van den Wyngaert T, Stroobants S, et al. Molecular Imaging of Apoptosis: the Case of Caspase-3 Radiotracers. Int J Mol Sci. 2021;22(8):3948. doi:10.3390/ijms22083948
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang H, Li D, et al. Caspase-3-mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway. J Cell & Mol Med. 2021;25(17):8159–8168. doi:10.1111/jcmm.16574
   PubMed Web of Science ®Google Scholar
• Kim HR, Cho YS, Chung SW, et al. Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic TNBC. J Control Release. 2022;346:136–147. doi:10.1016/j.jconrel.2022.04.014
   PubMed Web of Science ®Google Scholar
• Anbuselvam M, Easwaran M, Meyyazhagan A, et al. Structure-based virtual screening, pharmacokinetic prediction, molecular dynamics studies for the identification of novel EGFR inhibitors in breast cancer. J Biomol Struct Dyn. 2021;39(12):4462–4471. doi:10.1080/07391102.2020.1777899
   PubMed Web of Science ®Google Scholar
• Yin L, Duan JJ, Bian XW, et al. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22(1):61. doi:10.1186/s13058-020-01296-5
   PubMed Web of Science ®Google Scholar
• Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006;19(2):264–271. doi:10.1038/modpathol.3800528
   PubMed Web of Science ®Google Scholar
• Freitas-Alves DR, Vieira-Monteiro HA, Piranda DN, et al. PTGS2 polymorphism rs689466 favors breast cancer recurrence in obese patients. Endocr Relat Cancer. 2018;25(3):351–365. doi:10.1530/ERC-17-0374
   PubMed Web of Science ®Google Scholar
• Mori N, Mironchik Y, Wildes F, et al. HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracil. Curr Cancer Rep. 2020;2(1):54–63. doi:10.25082/CCR.2020.01.005
   PubMedGoogle Scholar
• Chen X, Ma N, Zhou Z, et al. Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells. Med Sci Monit. 2017;23:2674–2683. doi:10.12659/msm.904810
   PubMed Web of Science ®Google Scholar
• Christopoulos PF, Vlachogiannis NI, Vogkou CT, et al. The Role of the Androgen Receptor Signaling in Breast Malignancies. Anticancer Res. 2017;37(12):6533–6540. doi:10.21873/anticanres.12109
   PubMed Web of Science ®Google Scholar